Prevalence and characterization of metallo-beta-lactamases in clinical isolates of pseudomonas aeruginosa.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015780:Carbapenems / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000201:enzymology* / Q000235:genetics; D017422:Sequence Analysis, DNA; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000235:genetics / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D004269:DNA, Bacterial; D002442:Ceftazidime; D001618:beta-Lactamases